Detection by polymerase chain reaction of BCR/ ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation
Authors:
- 1 January 1995
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 31 (2) , 197-201
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft‐versus‐host disease and relapseBritish Journal of Haematology, 1993
- The Relationship Between the Type of bcr-abl Hybrid Messenger RNA and Thrombopoiesis in Philadelphia-Positive Chronic Myelogenous LeukemiaLeukemia & Lymphoma, 1993
- Graft vs. Leukaemia reactions in chronic myeloid leukaemiaEuropean Journal of Cancer, 1992
- The PCR revolutionEuropean Journal of Cancer, 1992
- The BCR gene encodes a novel serine/threonine kinase activity within a single exonCell, 1991
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- abl genesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1989
- Avoiding false positives with PCRNature, 1989
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984